Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|March 20, 2012
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaThomas Yau, P N Cheng, Pierre Chan, et al.
Cancers|May 4, 2026
Anti-Tumor Immunity in Solid-Organ Transplant RecipientsJeffrey Sum Lung Wong, Karen Hoi Lam Li, Bryan Li, et al.
The Lancet. Oncology|November 3, 2012
Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012Geoffrey Ku, Iain Beehuat Tan, Thomas Yau, et al.
JMIR Rehabilitation and Assistive Technologies|July 9, 2025
The Safety of Telerehabilitation: Systematic ReviewHila Shnitzer, Josh Chan, Thomas Yau, et al.
Plos One|November 19, 2024
Adverse events associated with the delivery of telerehabilitation across rehabilitation populations: A scoping reviewThomas Yau, Josh Chan, McKyla McIntyre, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Investigational New Drugs|February 11, 2015
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinomaThomas Yau, Paul N Cheng, Pierre Chan, et al.
Clinical and Translational Science|May 11, 2023
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)Bruno Sangro, Thomas Yau, Anthony B El-Khoueiry, et al.
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumabThomas Yau, Charles Swanton, Sue Chua, et al.
Plos One|February 21, 2024
Adverse events associated with the delivery of telerehabilitation: A scoping review protocolThomas Yau, McKyla McIntyre, Josh Chan, et al.
Pageof 14